- Home
- SFL vs CMPS Comparison
SFL vs CMPS Comparison
Compare SFL & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFL | CMPS |
|---|---|---|
| Founded | 2003 | 2020 |
| Country | Bermuda | United Kingdom |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SFL | CMPS |
|---|---|---|
| Price | $12.07 | $13.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $12.00 | ★ $25.38 |
| AVG Volume (30 Days) | 1.3M | ★ 3.6M |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.05% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.07 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.73 | $3.97 |
| 52 Week High | $12.94 | $15.40 |
Technical Indicators
Market Signals| Indicator | SFL | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 62.11 |
| Support Level | $9.95 | $10.66 |
| Resistance Level | $12.90 | $14.68 |
| Average True Range (ATR) | 0.29 | 0.72 |
| MACD | 0.03 | 0.18 |
| Stochastic Oscillator | 72.80 | 93.08 |
Price Performance
Historical ComparisonAbout SFL SFL Corporation Ltd
SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities. The company operates as a single reportable segment, generating revenue from long-term, fixed-rate charters. Its Additional revenue sources include sales-type lease interest income, voyage charter and pool revenues, and drilling contract revenues.
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.